QCG
MDGL icon

Quadrant Capital Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quadrant Capital Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Hold
2,605
– – 0.04% 449
2026
Q1 		$1.36M Hold
2,605
– – 0.04% 429
2025
Q4 		$1.52M Hold
2,605
– – 0.05% 354
2025
Q3 		$1.19M Hold
2,605
– – 0.04% 424
2025
Q2 		$788K Sell
2,605
-16
-0.6% -$4.77K 0.03% 605
2025
Q1 		$868K Buy
2,621
+2,599
+11,814% +$854K 0.03% 436
2024
Q4 		$6.79K Hold
22
– – ﹤0.01% 2236
2024
Q3 		$4.67K Hold
22
– – ﹤0.01% 2332
2024
Q2 		$6.16K Sell
22
-20
-48% -$4.76K ﹤0.01% 2246
2024
Q1 		$11.2K Buy
42
+20
+91% +$4.71K ﹤0.01% 2059
2023
Q4 		$5.09K Buy
22
+9
+69% +$1.57K ﹤0.01% 2273
2023
Q3 		$1.9K Sell
13
-1
-7% -$188 ﹤0.01% 2406
2023
Q2 		$3.23K Buy
14
+1
+8% +$271 ﹤0.01% 2306
2023
Q1 		$3.15K Sell
13
-30
-70% -$8.17K ﹤0.01% 2332
2022
Q4 		$12.5K Buy
+43
New +$4.21K ﹤0.01% 1847
2022
Q3 		– Sell
-3
Closed – – 2736
2022
Q2 		$0 Hold
3
– – ﹤0.01% 2654
2022
Q1 		$0 Buy
3
+2
+200% +$169 ﹤0.01% 2613
2021
Q4 		$0 Sell
1
-15
-94% -$1.23K ﹤0.01% 2626
2021
Q3 		$1K Buy
16
+14
+700% +$1.21K ﹤0.01% 2343
2021
Q2 		$0 Sell
2
-1
-33% -$118 ﹤0.01% 2491
2021
Q1 		$0 Buy
+3
New +$350 ﹤0.01% 2425
2020
Q2 		– Sell
-3
Closed – – 2327
2020
Q1 		$0 Buy
+3
New +$250 ﹤0.01% 2199

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrant Capital Group's MDGL Position: Q2 2026 in Review

Quadrant Capital Group held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 2,605 shares worth $1.4M. The position accounts for 0.04% of the portfolio, ranked #449.

Quadrant Capital Group first reported a position in MDGL in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.52M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Quadrant Capital Group held 2,605 shares of Madrigal Pharmaceuticals worth $1.4M as of Q2 2026.
  • Quadrant Capital Group left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.04% of Quadrant Capital Group's portfolio in Q2 2026, its #449 holding.
  • Quadrant Capital Group first reported a position in Madrigal Pharmaceuticals in Q1 2020 and has held it in 22 quarters since.
  • Quadrant Capital Group's Madrigal Pharmaceuticals position peaked at $1.52M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.